Metabolic Stress Triggers Immune Escape by Tumors

Joana B Nunes1, Bart Everts2

  • 1Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.

Trends in Cancer
|November 19, 2019
PubMed

Insights

Tumor cells evade immune attack when oxygen and glucose are low. This study reveals how low nutrient conditions decrease MHC class I expression, offering new therapeutic targets for cancer immunotherapy.

Area of Science:

  • Immunology
  • Cancer Biology
  • Molecular Signaling

Background:

  • The tumor microenvironment (TME) significantly influences cancer progression and immune evasion.
  • Understanding mechanisms of immune escape is crucial for developing effective cancer therapies.
  • Reduced surface expression of Major Histocompatibility Complex (MHC) class I molecules on tumor cells is a known immune evasion strategy.

Purpose of the Study:

  • To elucidate the signaling pathways by which low oxygen and glucose availability in the TME lead to decreased surface MHC class I expression on tumor cells.
  • To identify potential therapeutic targets for overcoming immune escape in cancer.

Main Methods:

  • The study likely involved in vitro experiments using cancer cell lines under controlled nutrient conditions (hypoxia and glucose deprivation).
  • Analysis of cell surface protein expression, potentially using flow cytometry.
  • Investigation of intracellular signaling pathways, possibly through Western blotting or gene expression analysis.

Main Results:

  • Low oxygen and glucose availability were shown to trigger a signaling cascade within tumor cells.
  • This cascade resulted in the downregulation of surface MHC class I expression.
  • Specific signaling molecules and pathways involved in this process were identified.

Conclusions:

  • Nutrient deprivation in the tumor microenvironment actively promotes immune evasion by reducing MHC class I presentation.
  • The identified signaling cascade represents a novel mechanism contributing to tumor immune escape.
  • Targeting this pathway could restore immune recognition of tumor cells and enhance immunotherapy efficacy.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
380
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K